B. Riley keeps Buy on BitMine Immersion, cuts price target to $27 from $34
B. Riley Securities kept its Buy rating on BitMine Immersion and lowered the price target to $27 from $34, a 20.6% cut, per TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Analysts at B. Riley Securities have kept their Buy rating on BitMine Immersion shares while lowering the price target to $27 from $34, a reduction of 20.6%, according to TradingView.
Based on reference data from Benzinga, which TradingView cites, the new target implies an upside of 46.3% from the November 12 close of $18.45. The report was published on November 13, 2026.
why it matters
The note reflects an analyst's view of the company rather than an event that moves the whole market. It contains no data on hashrate, network difficulty or bitcoin prices, so it does not by itself show how mining economics are changing. Analyst price targets are opinions and not a recommendation to trade.
tags
instruments
sources
- B. Riley Securities maintains Altimmune at Buy, lowers price target to $11 from $13 — TradingView, 13 November 2026 at 14:18 UTC
- B. Riley Securities maintains Journey Medical at Buy, lowers price target to $13 from $15 — TradingView, 13 November 2026 at 14:23 UTC
- B. Riley Securities maintains BitMine Immersion at Buy, lowers price target to $27 from $34 — TradingView, 13 November 2026 at 14:22 UTC
- B. Riley Securities maintains FuboTV at Buy, lowers price target to $16 from $18 — TradingView, 13 November 2026 at 14:27 UTC
- Truist Securities maintains ITG at Buy, lowers price target to $11 from $14 — TradingView, 13 November 2026 at 14:42 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗